Endoscopic therapy offers long-term survival rates similar to those for esophagectomy
Researchers in Florida examined national outcomes from endoscopic treatment compared with esophagectomy for 1,619 patients with early-stage esophageal adenocarcinoma. After findings were adjusted for patient and tumor-related factors, overall survival rates were similar. EQUIP significantly increases adenoma, polyp detection
Low adenoma detection rates (ADRs) in colonoscopy are linked to higher colorectal cancer risk. Most attempts to improve them have failed, but a new study shows a significant increase in ADRs after a brief educational intervention.
Opiod-sparing technique associated with reduced progression of prostate tumors
Research shows better outcomes in radical prostatectomy patients who had general anesthesia supplemented with spinal or epidural delivery of a long-acting opioid, such as morphine, compared with patients who received general anesthesia only.
|
Telomerase-inhibiting drug induces remission in some patients with myelofibrosis
In a clinical trial, imetelstat was found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis. Some patients taking imetelstat obtained dramatic or complete responses and some reverted back to normal bone marrow.
In-human trial of endoxifen provides evidence for tumor regression in patients who failed standard hormonal therapies
Z-endoxifen may provide a new and better treatment for some women with estrogen positive breast cancer and especially for women who do not respond to tamoxifen and aromatase inhibitors.
Researchers reduce radiation exposure for patients while maintaining CT scan image quality
At a time when computerized tomography (CT) scans are being used with greater frequency, the work of Mayo Clinic's CT Clinical Innovation Center has cut the risk of exposure without sacrificing image quality or diagnostic capability.
See all Cancer Clinical Trials at Mayo Clinic
|
Breast, Ovarian and Lung Cancer: Screening, Diagnosis and Personalized Management in 2014
Feb. 21-22, 2014, in Jacksonville, Fla.
Review breast, gynecologic and lung cancer screening and therapy. Small group interactive sessions address genetics, radiologic techniques, diagnostic biopsy steps and pathological concepts with emphasis on molecular diagnosis and individualization of cancer therapy based on molecular phenotype.
Transoral Surgery for Head and Neck Cancer
Feb. 27-March 1, 2014, in Phoenix
This course covers transoral endoscopic techniques for resecting primary head and neck tumors, including transoral laser and robotic surgery and flexible laser surgery in inpatient and outpatient environments. An optional cadaveric workshop offers opportunities to perform various transoral procedures.
TransFuse 2014: Transformative-Fusion of Innovative Patient Blood Management
March 26-28, 2104, in Phoenix
Learn to implement a blood management program in hospitals. Topics include optimization of blood transfusions in the hospitalized patient, demonstrated surgical hemostatic techniques, and descriptions of the adverse consequences of allogeneic transfusions and their effect on patient outcomes.
See all Hematology & Oncology Continuous Professional Development courses |